Trihexyphenidyl for dystonia in cerebral palsy
LB Baker, AR Harvey, KJ Egberts, DS Reddihough, A Scheinberg, K Williams
Cochrane Database of Systematic Reviews | Published : 2016
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of trihexyphenidyl on the World Health Organisation's (WHO) International Classification of Functioning, Disability and Health (ICF) domains of impairment, activity, and participation in individuals with dystonic cerebral palsy. To assess the type and incidence of adverse effects from the use of trihexyphenidyl in individuals with dystonic cerebral palsy.